AstraZeneca to acquire EsoBiotec for up to $1B
The UK’s leading biopharmaceutical company AstraZeneca announced on Monday that it entered into a definitive agreement to acquire biotechnology company EsoBiotec SA for up to $1 billion in cash.”We lo…
The UK’s leading biopharmaceutical company AstraZeneca announced on Monday that it entered into a definitive agreement to acquire biotechnology company EsoBiotec SA for up to $1 billion in cash.”We lo…
